SB939 restores IM sensitivity in CML CD34-positive cells displaying the intronic deletion polymorphism of the BIM gene by repairing its pre-mRNA splicing, suggesting that patients presenting this polymorphism, may benefit from the combination of SB939 and IM [87]. The gene discussed is CD34; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.